pioglitazone has been researched along with Coronary Vasospasm in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Coronary Vasospasm: Spasm of the large- or medium-sized coronary arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morita, S | 1 |
| Mizuno, Y | 1 |
| Harada, E | 1 |
| Kashiwagi, Y | 1 |
| Yoshimura, M | 1 |
| Murohara, T | 1 |
| Yasue, H | 1 |
1 trial available for pioglitazone and Coronary Vasospasm
| Article | Year |
|---|---|
Pioglitazone, a peroxisome proliferator-activated receptor γ activator, suppresses coronary spasm.
Topics: Acetylcholine; Aged; Angina Pectoris; Calcium Channel Blockers; Coronary Angiography; Coronary Vasos | 2014 |